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Letter to the Editor
The p.P56S mutation in the VAPB gene
is not due to a single founder: the ﬁrst
European case
To the Editor:
A dominant missense mutation p.P56S in the
vesicle associated membrane protein associated
protein B (VAPB) gene was described in eight
Brazilian families of Portuguese descent show-
ing a wide spectrum of motor neuron diseases
(MNDs) including spinal muscular atrophy (SMA)
and familial amyotrophic lateral sclerosis (ALS)
(ALS8) (1, 2). Haplotype analysis indicated a com-
mon ancestor with a founding event 23 generations
previously, when this ancestor was still living in
Portugal (3). We report the ﬁrst identiﬁcation of
the p.P56S mutation in the VAPB gene in a non-
Brazilian patient.
A 43-year-old man (III-1) showed slowly pro-
gressive muscular weakness for 2 years and a fam-
ily history of autosomal dominant neuromuscular
disease through at least three generations (Fig 1).
The patient’s mother (II-1) suffered from slowly
progressive muscular weakness over 30 years. No
pyramidal tract signs had been observed. She was
wheelchair bound 20 years after onset and died at
the age of 67. The maternal grandfather (I-1) had
a history of progressive muscular weakness, had
died aged 57 and had six siblings. Three (I-5, I-6,
I-7) suffered from muscular weakness. One cousin
of the patient’s mother (II-2) was diagnosed with
SMA. There was no family record of Portuguese
or Brazilian ancestors in at least four previous
generations. All family members originated from
northern Germany.
The index patient (III-1) showed paresis of the
hip ﬂexors and extensors (Medical Research Coun-
cil (MRC) grade 4/5) and fasciculations in the
proximal muscles of arms, legs on both sides. Deep
tendon reﬂexes were normal except for absent
Achilles tendon reﬂexes. There were no pyrami-
dal tract signs. Needle electromyography showed
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Fig. 1. Family tree. Family members who are deemed affected
based upon family history are marked gray. It is not known
if family members I-2, I-3, I-4, I-5, I-6, I-7, and II-2 are still
alive.
fasciculations and signs of chronic denervation.
Nerve conduction studies of tibial nerves revealed
slightly reduced amplitudes on the left. Motor
evoked potentials in both tibialis anterior muscles
after magnetic stimulation of the motor cortex and
the lumbar roots were normal.
Genomic DNA of the index case was extracted
from peripheral blood and ampliﬁed using primer
pairs ﬂanking all exons and exon/intron boundaries
of the VAPB gene. Amplicons were puriﬁed and
sequenced directly on an ABI PRISM 310 Genetic
Analyzer (PE, Applied Biosystems). The p.P56S
mutation was screened in 100 German healthy
controls. Haplotype analysis was performed using
microsatellite markers D20S100, D20S171 and
D20S173 from the ABI Prism Linkage Mapping
Set kit version 2 (Applied Biosystems, Foster
City, CA) as reported previously (3). The forward
5 AAGACAAGCAAAACTAAAGAACTGC3 and
reverse 5 TTCCCATTACCGGTTATCCA-3  pri-
mers were used to amplify part of 3  UTR sequence
of the tubulin beta 1 (TUBB1) gene. A poly-
morphism in this region was used as intrafa-
milial marker. Polymerase chain reaction prod-
ucts were analyzed using a MegaBace 1000 DNA
Sequencer (Amersham Bioscience, Little Chalfont,
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Table 1. Haplotype comparison of the German index patient and the patients from three different Brazilian families with the p.P56S
vesicle associated membrane protein associated protein B (VAPB) gene mutationa
Brazilian families
Position (Mb) Marker German index patient 1 2 3
53.74 D20S100 222 232 224 230 226 230 232 230
57.0 TUBB1 G G G C G C G C
57.24 D20S171 142 142 142 144 144 144 140 144
58.31 D20S173 176 178 178 178 176 178 178 178
aThe haplotype given in boldface signiﬁes the ancestral allele in the Brazilian families.
UK). DNA from the index patient was compared
to three affected individuals from three different
kindreds of the Brazilian families.
Sequencing revealed a heterozygous p.P56S
point mutation in exon 2 of the VAPB gene. This
mutation was not present in 200 German control
chromosomes. Haplotype analysis revealed that
this patient had a different haplotype compared to
the Brazilian families (Table 1).
The phenotype of our index case and his mother
represented late onset SMA as observed in one-
third of the Brazilian patients carrying the p.P56S
VAPB mutation (1). Although we cannot entirely
exclude the possibility of Brazilian or Portuguese
ancestors, haplotype analysis showed that our
patient’s mutation is not due to the same founder
as in the reported Brazilian patients. Therefore,
we assume that the p.P56S mutation happened in
at least two independent events. Several studies
failed to identify VAPB mutations in cohorts
of patients with ALS (4–6)]. Mutations in the
VAPB gene seem to be rare in familial MNDs.
However, our case report demonstrates that the
p.P56S mutation can be observed outside Brazil,
and should be considered as a rare differential
diagnosis in familial MNDs.
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